Registering a CAGR of 8.9% over the forecast period of 2022-2027, the global Biopharmaceutical Packaging Market is anticipated to reach the market value of US$98.2 Billion in the year 2020 from US$161.6 Billion by 2027.
Biopharmaceuticals are medicinal drugs that are industrial by means of biotechnology. They are mostly proteins (antibodies), nucleic acids (DNA, RNA) which are commonly used for in vivo or therapeutic purposes. Biopharmaceutical packaging theatres a very significant role in maintaining the product quality and characteristics of the drugs. Biopharmaceuticals are very subtle to the temperature and the environment to which they are being exposed, thereby biopharmaceuticals packaging act as a shield to the biological or biopharmaceutical products by temperature regulation and without causation any damage to the product. Biopharmaceuticals are used over many terminal conditions on which there are negligible chances of working with the conventional drug or medicine.
Furthermore, the biopharmaceutical producers are seeking new methods for promoting and protecting their products, meeting new regulations, and growing patient compliance which will uplift the claim for the biopharmaceuticals packaging market. Thereby, owing to the above factors, the biopharmaceutical packaging market is projected to gain a certain claim in the coming years.
April 20, 2022: Amcor launches more sustainable packaging for pharmaceuticals--
Amcor (NYSE: AMCR; ASX: AMC), a global leader in developing and producing responsible packaging solutions, today announced the addition of new, more sustainable High Shield laminates to its pharmaceutical packaging portfolio. The new low carbon, recycle-ready packaging options deliver on two fronts, providing the high barrier and performance requirements needed for the industry while supporting pharmaceutical companies’ recyclability agendas.
12/16/2021: Gerresheimer enters into an agreement with major American biotech to develop an innovative pump for rare diseases--
Gerresheimer has entered into an important agreement involving its Advanced Technologies division. An established US biotech company will rely on Gerresheimer's innovative strength and engineering expertise for the development of a new pump to deliver a leading drug for the treatment of rare diseases via continuous parenteral administration.
The biopharmaceutical Packaging Market is segmented based on the type, applications, companies, and regions.
By Type, it is segmented into
By Applications, it is segmented into
North America dominated the market in 2021, with a revenue share of more than 35.0%. In 2021, pharma manufacturing, which includes in-house production, was the region's largest end-use segment. The United States' 21st Century Cures Act (Cures Act) was signed on December 13, 2016, to speed up the development of medical products. The rule is intended to spur pharmaceutical sector product innovation, which will stimulate demand for pharmaceutical packaging in North America.
Asia Pacific is expected to register the fastest CAGR of 12.9% from 2021 to 2030. Growing consumer health awareness in Asia Pacific, particularly in developing nations like as China and India, combined with rising disposable income levels, is expected to drive pharmaceutical sector growth over the projection period. This is projected to boost pharmaceutical packaging demand. Due to increased government efforts such as Healthy China 2020, significant contract manufacturing operations, and a rapidly ageing population, China dominated the Asia Pacific market in 2021 and will continue to do so in the future years.
Europe is expected to witness considerable growth over the forecast period owing to the rising research & development activities and the introduction of new medicines aimed at improving patient health and their quality of life. Companies such as BioNTech SE and CureVac in Europe have proven success in their vaccines in 2020, which has been further attracting investments in the biotech industry in countries, such as Germany, Russia, and the U.K.
Report Attributes | Report Details |
Forecast Period 2022 to 2027 CAGR | CAGR of 8.9% over the forecast period (2022-2027) |
By Type |
|
By Application |
|
By Companies | Gerresheimer, Amcor, ACG, Schott, DowDuPont, West-P, Bilcare, Nipro, AptarGroup, Svam Packaging, Bemis Healthcare, Datwyler, NGPACK, Jal Extrusion, SGD |
Regions Covered |
|
Countries Covered |
|
Base Year | 2022 |
Historical Year | 2017 to 2021 |
Forecast Year | 2022 to 2027 |
Number of Pages | 111 |
Customization Available | Yes, the report can be customized as per your needs |
What is the growth rate of Biopharmaceutical Packaging Market?
The Biopharmaceutical Packaging Market is growing at a CAGR of 8.9% over the next 5 years.
Who are the key players in Biopharmaceutical Packaging Market?
Gerresheimer, Amcor, ACG, Schott, DowDuPont, West-P, Bilcare, Nipro, AptarGroup, Svam Packaging, Bemis Healthcare, Datwyler, NGPACK, Jal Extrusion, SGD
What are the significant types of Biopharmaceutical Packaging Market?
Plastic and Polymers, Paper & Paperboard, Glass, Aluminum Foil, Others
What are the major end-use applications of Biopharmaceutical Packaging Market?
Oral Drugs, Injectable, Others
On the basis of type, Which segment is likely to hold the major share in the Biopharmaceutical Packaging Market?
Plastic and Polymers segment to hold the largest share in Biopharmaceutical Packaging market
All our reports are custom made to your company needs to a certain extent, we do provide 5 free consulting hours along with the purchase of each report, and this will allow you to request any additional data to customize the report as your needs.
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.
Reach us with your research requirements and we shall provide the optimum solution to suit your needs.
Discounts available for multiple report purchases.